177Lu-R10306

N/A

Report date: 2026/03/13 20:02:36

NME

Base Information

Drug Name177Lu-R10306

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > LutetiumDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesC-Ray Therapeutics (Chengdu) Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesC-Ray Therapeutics (Chengdu) Co Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A